Palau L A, Pankey G A
Department of Internal Medicine, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121, USA.
Am J Trop Med Hyg. 1997 Oct;57(4):413-5. doi: 10.4269/ajtmh.1997.57.413.
Strongyloides hyperinfection and dissemination are recognized complications in kidney allograft recipients; however, the development of strongyloidiasis in renal transplant recipients receiving cyclosporine A (CyA) has not been described, nor has the development of strongyloidiasis in other organ transplant recipients. The former observation has been attributed to the antiparasitic activity of CyA seen in animal studies; the latter has no explanation yet. We report the first case of Strongyloides hyperinfection in a renal transplant patient occurring immediately after CyA was discontinued. From the unique characteristics of this case, it appears that the anti-Strongyloides activity of CyA in animals may also be found in humans.
粪类圆线虫重度感染和播散是肾移植受者公认的并发症;然而,接受环孢素A(CyA)的肾移植受者中粪类圆线虫病的发生情况尚未见报道,其他器官移植受者中粪类圆线虫病的发生情况也未见报道。前一种观察结果归因于动物研究中发现的CyA的抗寄生虫活性;后一种情况尚无解释。我们报告了首例肾移植患者在停用CyA后立即发生粪类圆线虫重度感染的病例。从该病例的独特特征来看,CyA在动物中的抗粪类圆线虫活性在人类中可能也存在。